Screening for the second leading cause of cancer deaths just got a bit easier. The U.S. Food and Drug Administration (FDA) announced the approval of a new blood test for colorectal cancer (CRC).
Changes in screening recommendations over a decade ago may have inadvertently resulted in later diagnosis of the most common cancer in men, a new study has found. By Roni Caryn Rabin Prostate cancer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback